Publication: Increased endothelial activation in α-thalassemia disease
1
Issued Date
2019-07-01
Resource Type
ISSN
14320584
09395555
09395555
Other identifier(s)
2-s2.0-85064485474
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Annals of Hematology. Vol.98, No.7 (2019), 1593-1602
Suggested Citation
Pankamol Sirivadhanakul, Ampaiwan Chuansumrit, Duantida Songdej, Praguywan Kadegasem, Pakawan Wongwerawattanakoon, Nongnuch Sirachainan Increased endothelial activation in α-thalassemia disease. Annals of Hematology. Vol.98, No.7 (2019), 1593-1602. doi:10.1007/s00277-019-03672-4 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/51549
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Increased endothelial activation in α-thalassemia disease
Other Contributor(s)
Abstract
© 2019, Springer-Verlag GmbH Germany, part of Springer Nature. One complication of thalassemia is thromboembolism (TE), which is caused by an abnormal red blood cell surface, as well as endothelial and platelet activation. These findings are commonly observed in severe β-thalassemia. However, limited information on α-thalassemia exists. This study enrolled subjects with deletional and non-deletional α-thalassemia and normal controls (NC). Plasma and serum of subjects were tested for endothelial activation markers including thrombomodulin (TM), vascular cell adhesion molecule-1 (VCAM-1), and von Willebrand factor antigen as well as platelet activation markers including thromboxane B2 and platelet factor 4. A total of 179 subjects were enrolled: 29 in the deletional group (mean age 13.3 ± 4.4 years), 31 in the non-deletional group (mean age 12.9 ± 4.8 years), and 119 in the NC group (mean age 13.6 ± 3.0 years). Twenty nine percent of subjects in the non-deletional group received regular red blood cell transfusion and iron chelator administration. Serum ferritin level was higher in the non-deletional group than that in the deletional group. Multivariate analysis demonstrated that VCAM-1 and TM levels were increased significantly in α-thalassemia compared with NC group (816.8 ± 131.0 vs 593.9 ± 49.0 ng/ml, and 4.9 ± 0.7 vs 4.0 ± 0.4 ng/ml, P < 0.001 respectively). VCAM-1 and TM levels in the non-deletional group were significantly higher than that in the deletional group. The present study demonstrated endothelial activation in children with α-thalassemia disease, especially those in the non-deletional group, which might be one risk factor for TE in α-thalassemia disease.